Microbiota-Driven Mechanisms in Endometrial Cancer Pathogenesis: Focus on Lynch Syndrome
Current Oncology · 17.11.2026 · 33 (11) · 710
DOI: 10.3390/curroncol33110710 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, online erschienen am 17.11.2026. Verfasst von Silvia Actis und 9 weiteren Autor:innen. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Lynch syndrome is the most common hereditary syndrome predisposing to endometrial cancer, but the mechanisms contributing to tumor development remain incompletely understood. This review aimed to summarise current evidence on the composition and potential pathogenic role of the microbiota in Lynch syndrome-associated endometrial cancer and to explore its clinical implications. A systematic literature search of PubMed/MEDLINE and Embase was conducted between October and November 2025 using predefined terms related to microbiota, carcinogenesis, endometrial cancer, and Lynch syndrome. Available evidence suggests that alterations in the microbiota may contribute to carcinogenesis through chronic inflammation, immune modulation, metabolic changes, and bacterial genotoxicity. Studies in Lynch syndrome carriers with endometrial or colorectal cancer report an increased abundance of potentially pro-inflammatory Gram-negative bacteria, including Bacteroides fragilis and Fusobacterium nucleatum, together with a reduction in short-chain fatty acid-producing bacteria such as Faecalibacterium, Blautia, and Butyrivibrio. Microbial metabolites, including butyrate, may have protective effects, whereas bacterial β-glucuronidase activity may increase estrogen bioavailability and contribute to a tumor-promoting environment. Emerging evidence also suggests that the microbiota may influence treatment response and toxicity. Overall, current evidence supports a potential role for the microbiota in Lynch syndrome-associated endometrial carcinogenesis, although data remain limited. Further studies are needed to determine whether microbiota profiling could contribute to risk stratification, prevention, and personalized therapeutic strategies.
Zitieren
APA
Actis, S., Cazzaniga, M., D’Alonzo, M., Perrini, G., Giorgi, M., Pace, L., Pascotto, M., Campigotto, B., Ferrero, A., & Bounous, V. E. (2026). Microbiota-Driven Mechanisms in Endometrial Cancer Pathogenesis: Focus on Lynch Syndrome. Current Oncology, 33(11), 710. https://doi.org/10.3390/curroncol33110710
Vancouver
Actis S, Cazzaniga M, D’Alonzo M, Perrini G, Giorgi M, Pace L, et al. Microbiota-Driven Mechanisms in Endometrial Cancer Pathogenesis: Focus on Lynch Syndrome. Current Oncology. 2026;33(11):710. doi:10.3390/curroncol33110710
BibTeX
@article{Actis2026,
author = {Actis, Silvia and Cazzaniga, Massimiliano and D’Alonzo, Marta and Perrini, Gaetano and Giorgi, Margherita and Pace, Luca and Pascotto, Maria and Campigotto, Beatrice and Ferrero, Annamaria and Bounous, Valentina Elisabetta},
title = {Microbiota-Driven Mechanisms in Endometrial Cancer Pathogenesis: Focus on Lynch Syndrome},
journal = {Current Oncology},
year = {2026},
volume = {33},
number = {11},
pages = {710},
doi = {10.3390/curroncol33110710}
}
EUVIMED